Consistent beneficial effect with GLP-1RA across broad range of kidney function and kidney damage - PACE-CME

Consistent beneficial effect with GLPRA across broad range of kidney function and kidney damage

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

2022 ADA/EASD consensus report on management of hyperglycemia in T2DM
2022 ADA/EASD consensus report on management of hyperglycemia in T2DM
EASD 2022
2022 ADA/EASD consensus report on management of hyperglycemia in T2DM
- Prof. John Buse, MD, PhD
SGLT2i reduces outcomes in HFmrEF and HFpEF regardless of glycemic status
SGLT2i reduces outcomes in HFmrEF and HFpEF regardless of glycemic status
EASD 2022
SGLT2i reduces outcomes in HFmrEF and HFpEF regardless of glycemic status
- Pardeep Jhund, MD, PhD
Greater intake of sodium and protein may predispose to deeper fall in GFR after start of SGLT2i
Greater intake of sodium and protein may predispose to deeper fall in GFR after start of SGLT2i
EASD 2022
Greater intake of sodium and protein may predispose to deeper fall in GFR after start of SGLT2i
- Marta Seghieri, MD